ILL-DEFINED DISORDER

This adverse event was reported 60810 times

These drugs are most commonly taken by patients reporting ILL-DEFINED DISORDER:

# Drug Count
0 OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN 6435
1 PREDNISONE 5690
2 METHOTREXATE SODIUM 5362
3 ETANERCEPT 5172
4 METHOTREXATE 5089
5 ACETAMINOPHEN 5075
6 TOCILIZUMAB 5046
7 RITUXIMAB 4772
8 LEFLUNOMIDE 4453
9 ADALIMUMAB 4255
See all common drugs associated with ILL-DEFINED DISORDER

ILL-DEFINED DISORDER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN 6435 0.5274
1 GOLIMUMAB 3754 0.2981
2 LUTETIUM LU 177 DOTATATE 1542 0.2650
3 LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN 3641 0.2631
4 CAFFEINE CITRATE 463 0.1984
5 DESOGESTREL AND ETHINYL ESTRADIOL 650 0.1983
6 NEOMYCIN OINTMENT 477 0.1945
7 HYDROCORTISONE BUTYRATE 328 0.1660
8 DESOXIMETASONE 2985 0.1549
9 CORTISONE ACETATE 1904 0.1523
See all drugs enriched for association with ILL-DEFINED DISORDER

ILL-DEFINED DISORDER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 1049 1.5247
1 Radioligand Therapeutic Agent [EPC] 3641 0.2631
2 Endoglycosidase [EPC] 255 0.1376
3 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 783 0.0898
4 Provitamin D2 Compound [EPC] 2389 0.0803
5 Interleukin-17A Antagonist [EPC] 2659 0.0713
6 Antirheumatic Agent [EPC] 4456 0.0421
7 Interleukin-6 Receptor Antagonist [EPC] 5171 0.0373
8 Aminosalicylate [EPC] 3559 0.0353
9 Histamine-1 Receptor Antagonist [EPC] 2772 0.0329
See all drug classes enriched for association with ILL-DEFINED DISORDER